In the original article, there was a mistake in Table 1 as published. The study conducted by Veronez et al. (2018) did not focus on acquired forms of angioedema (AAE). In addition, the study published in 2017 by the same author, describes a rare mutation detected within F12 gene in a patient with angioedema induced by angiotensin-converting enzyme inhibitors. The reference (Veronez et al., 2018) has been modified to Veronez et al. (2017). Besides, one of the gene acronyms “BDKRB2” was not set in italics. This is has been corrected and shown in Table 1 below.
Table 1
| Sample size (cases: controls) | ||||||
|---|---|---|---|---|---|---|
| Year | Type of study | Discovery | Replication | Population | Gene(s) | References |
| 2017 | Candidate gene in a case report | – | – | Multiethnic | F12 | Veronez et al. (2017) |
| 2013 | GWAS | 175: 489 | 19:57 | Multiethnic | MME (top) | Pare et al. (2013) |
| 2013 | Candidate gene | 52: 77 | – | Multiethnic | BDKRB2 | Moholisa et al. (2013) |
| 2013 | Candidate gene‡ | 223: 584 | – | Multiethnic | XPNPEP2 | Mahmoudpour et al. (2013) |
| 2011 | Candidate gene | 34: 127 | – | Multiethnic | XPNPEP2 | Cilia La Corte et al. (2011) |
| 2010 | Candidate gene | 169: 397 | – | Multiethnic | XPNPEP2 | Woodard-Grice et al. (2010) |
| 2010 | Candidate gene | 65: 65 | – | Unreported | ACE, BDKRB2 | Bas et al. (2010) |
| 2008 | Candidate gene | 32: 96 | – | Unreported | ACE | Gulec et al. (2008) |
| 2008 | Candidate gene | 95: 161 | – | Multiethnic | ACE | Akcali et al. (2008) |
| 2006 | Candidate gene in a case report | – | – | Unreported | F5 | Osmanagaoglu et al. (2006) |
| 2006 | Candidate gene in families | 14 | – | Unreported | XPNPEP2 | Molinaro et al. (2006) |
| 2005 | Candidate gene† | 20: 60 | – | European | XPNPEP2 | Duan et al. (2005) |
Genetic studies of acquired bradykinin-mediated angioedema (Bk-AE) published until 2018.
Association study following a linkage analysis of a quantitative trait in families affected by Bk-AE. GWAS, Genome-wide association study.
Meta-analysis.
Also, we stated that in the study conducted by Dewald (2018) there is another rare variant affecting function detected within PLG gene. However, this is the same variant (p.Lys330Glu) described by Bork et al. (2018). This error was caused by the use of different nomenclature, where Bork et al., uses the correct nomenclature indicated by the Human Genome Variation Society guidelines. At the moment, only one PLG causal variant affecting function is reported in the scientific literature. A correction has been made to the third paragraph of Section: NGS to Fully Define HAE Genetics:
Another recent WES study in families with HAE-nC1-INH with unknown genetic causes identified the plasminogen gene (PLG) as a new causal gene (Bork et al., 2018). In this case, a p.Lys330Glu variant located in exon 9 was found in 14 German patients while it was absent from gnomAD. This variant predicted a change in the kringle 3 domain of plasminogen. The variant was found in all symptomatic patients and in nine out of 38 index patients from other independent families. In fact, two other studies identified the same variant in HAE cases from France and Japan (Belbézier et al., 2018; Yakushiji et al., 2018). Another study screened PLG for variants in eight unrelated index patients from Germany with HAE-nC1-INH with unknown genetic causes (Dewald, 2018). They also found the rare non-conservative missense variant in exon 9 (p.Lys330Glu) in three of the patients, using isoelectric focusing of plasma samples followed by an immunoblotting procedure, this study demonstrated that the presence of the p.Lys330Glu variant was associated with the presence of an aberrant plasminogen protein.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
References
1
AkcaliC.OzkurM.ErbagciZ.BenlierN.AynaciogluA. S. (2008). Association of insertion/deletion polymorphism of the angiotensin-converting enzyme gene with angio-oedema accompanying chronic urticaria but not chronic urticaria without angio-oedema or the autologous serum skin test response. J. Eur. Acad. Dermatol. Venereol.22, 83–86. 10.1111/j.1468-3083.2007.02353.x
2
BasM.HoffmannT. K.TiemannB.DaoV. T.BantisC.BalzV.et al. (2010). Potential genetic risk factors in angiotensin-converting enzyme-inhibitor-induced angio-oedema. Br. J. Clin. Pharmacol.69, 179–186. 10.1111/j.1365-2125.2009.03567.x
3
BelbézierA.HardyG.MarluR.DefendiF.Dumestre PerardC.Boccon-GibodI.et al. (2018). Plasminogen gene mutation with normal C1 inhibitor hereditary angioedema: three additional French families. Allergy73, 2237–2239. 10.1111/all.13543
4
BorkK.WulffK.Steinmüller-MaginL.BraenneI.Staubach-RenzP.WitzkeG.et al. (2018). Corrigendum. Allergy73:2412. 10.1111/all.13623
5
Cilia La CorteA. L.CarterA. M.RiceG. I.DuanQ. L. (2011). A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema. Hum. Mutat.32, 1326–1331. 10.1002/humu.21579
6
DewaldG. (2018). A missense mutation in the plasminogen gene, within the plasminogen kringle 3 domain, in hereditary angioedema with normal C1 inhibitor. Biochem. Biophys. Res. Commun.498, 193–198. 10.1016/j.bbrc.2017.12.060
7
DuanQ. L.NikpoorB.DubeM.-P.MolinaroG.MeijerI. A.DionP.et al. (2005). A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am. J. Hum. Genet.77, 617–626.
8
GulecM.CaliskanerZ.TuncaY.OzturkS.BozogluE.GulD.et al. (2008). The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers. Allergol. Immunopathol.36, 134–140. 10.1016/S0301-0546(08)72537-0
9
MahmoudpourS. H.LeusinkM.van der PuttenL.TerreehorstI.AsselbergsF. W.de BoerA.et al. (2013). Pharmacogenetics of ACE inhibitor-induced angioedema and cough: a systematic review and meta-analysis. Pharmacogenomics14, 249–260. 10.2217/pgs.12.206
10
MoholisaR. R.RaynerB. R.Patricia OwenE.SchwagerS. L. U.StarkJ. S.BadriM.et al. (2013). Association of B 2 receptor polymorphisms and ACE activity with ACE inhibitor-induced angioedema in black and mixed-race South Africans. J. Clin. Hypertens.15, 413–419. 10.1111/jch.12104
11
MolinaroG.DuanQ. L.ChagnonM.MoreauM. E.SimonP.ClavelP.et al. (2006). Kinin-dependent hypersensitivity reactions in hemodialysis: metabolic and genetic factors. Kidney Int.70, 1823–1831. 10.1038/sj.ki.5001873
12
OsmanagaogluM. A.OkumuşB.BozkayaH. (2006). Skin venous thromboembolism by combined oral contraceptive in a woman with acquired angioedema and Factor V Leiden mutation. Contraception73, 311–314. 10.1016/j.contraception.2005.09.006
13
PareG.KubojM.ByrdJ. B.McCartyC. A.Woodard-GriceA.TeoK. K.et al. (2013). Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenet. Genomics23, 470–478. 10.1038/jid.2014.371
14
VeronezC. L.MorenoA. S.Constantino-SilvaR. N.MaiaL. S. M.FerrianiM. P. L.CastroF. F. M.et al. (2018). Hereditary angioedema with normal C1 inhibitor and F12 mutations in 42 Brazilian families. J. Allergy Clin. Immunol. Pract.6, 1209–1216.e8. 10.1016/j.jaip.2017.09.025
15
VeronezC. L.SerpaF. S.PesqueroJ. B. (2017). A rare mutation in the F12 gene in a patient with ACE inhibitor-induced angioedema. Ann. Allergy Asthma Immunol. 118, 743–745. 10.1016/j.anai.2017.04.014
16
Woodard-GriceA. V.LucisanoA. C.ByrdJ. B.StoneE. R.SimmonsW. H.BrownN. J. (2010). Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenet. Genomics20, 532–536. 10.1097/FPC.0b013e32833d3acb
17
YakushijiH.HashimuraC.FukuokaK.KajiA.MiyaharaH.KanameS.et al. (2018). A missense mutation of the plasminogen gene in hereditary angioedema with normal C1 inhibitor in Japan. Allergy73, 2244–2247. 10.1111/all.13550
Summary
Keywords
angioedema, inheritance, diagnosis, sequencing, precision medicine
Citation
Marcelino-Rodriguez I, Callero A, Mendoza-Alvarez A, Perez-Rodriguez E, Barrios-Recio J, Garcia-Robaina JC and Flores C (2020) Corrigendum: Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics. Front. Genet. 11:690. doi: 10.3389/fgene.2020.00690
Received
30 April 2020
Accepted
05 June 2020
Published
28 July 2020
Volume
11 - 2020
Edited and reviewed by
Anastasios E. Germenis, University of Thessaly, Greece
Updates
Copyright
© 2020 Marcelino-Rodriguez, Callero, Mendoza-Alvarez, Perez-Rodriguez, Barrios-Recio, Garcia-Robaina and Flores.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Carlos Flores cflores@ull.edu.es
This article was submitted to Genomic Medicine, a section of the journal Frontiers in Genetics
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.